The DIA 2024 Global Annual Meeting invites industry, regulators, governments, academics, innovators, and patients to network, problem-solve, and discuss global and local challenges facing the life sciences community. Hosted in San Diego, DIA 2024 will amplify different perspectives while highlighting expertise across the globe to reimagine current processes that better enhance health and well-being.

Since 2010, this important conference continues to focus on the field of genome and epigenome editing. The meeting will focus on new tools and technologies, understanding the biology of editors and their outcomes, new classes of precise editors, plant and animal modeling with precise genome editing, and clinical trials of genome editors.

This inaugural conference topic will examine how ion channels and transporters (ICTs) control key aspects of intracellular signaling and cell physiology. Relatively little is known about how ICTs regulate immune responses in the context of inflammation, asthma, allergies, autoimmune diseases, anti-tumor immunity, and infection. The program will cover a range of topics including ICT functions...

Since 1987, this Science Research Conference (SRC) has fostered a highly interactive community of researchers focused on solving important problems in immunoreceptor and immunotherapy biology. It brings together international scientists from academia, government, and industry to discuss cutting-edge developments in this exciting area of research.  

Since 2016, this conference has brought together investigators focused on basic mechanisms of cancer development, translational research, and early-phase clinical research. This year’s program will focus on genetic and molecular mechanisms underlying tumorigenesis that can be exploited for the development of novel forms of therapy. The sessions will disseminate the most up-to-date knowledge and newest...

The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. RESI maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development. RESI is uniquely cross-border and cross-domain, connecting start-ups with 10 categories of global investors across the silos of drugs, devices, diagnostics and...

Biotech is brimming with ideas. The issue comes in moving new drugs from lab bench to patient bedside as the industry tightens its belt. Our panel will delve into the good, the bad and what’s exciting in the Bay Area biotech ecosystem, and two life sciences leaders will talk one-on-one on the opportunities and challenges...